These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10853136)

  • 1. Three-dimensional conformal radiation therapy: what are the costs and benefits?
    Horwitz EM; Hanks GE
    Surg Oncol Clin N Am; 2000 Jul; 9(3):455-67, viii. PubMed ID: 10853136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The cost of radiotherapy].
    Martin P
    Bull Cancer; 2003 Nov; 90(11):969-75. PubMed ID: 14706900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changing costs of radiation treatment for early prostate cancer in Ontario: a comparison between conventional and conformal external beam radiotherapy.
    Poon I; Pintilie M; Potvin M; McGowan T
    Can J Urol; 2004 Feb; 11(1):2125-32. PubMed ID: 15003151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Economic aspects of conformal radiotherapy].
    Martin P; Dubray B
    Cancer Radiother; 1999; 3(5):437-40. PubMed ID: 10572513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformal radiotherapy: what is it and why does it matter?
    Cardinale RM; Kavanagh BD
    Surg Oncol Clin N Am; 2000 Jul; 9(3):415-34, vii. PubMed ID: 10853134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.
    Zelefsky MJ; Fuks Z; Hunt M; Lee HJ; Lombardi D; Ling CC; Reuter VE; Venkatraman ES; Leibel SA
    J Urol; 2001 Sep; 166(3):876-81. PubMed ID: 11490237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness studies in radiation therapy.
    Sher DJ
    Expert Rev Pharmacoecon Outcomes Res; 2010 Oct; 10(5):567-82. PubMed ID: 20950072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intensity modulated radiotherapy (IMRT) in France: The boost of the national funding for the new expensive innovative technologies (STIC 2001 and 2002)].
    Marchal C; Bensadoun RJ; Haslé E; Lapeyre M; Carrere MO; Gérard JP
    Cancer Radiother; 2003 Nov; 7 Suppl 1():44s-48s. PubMed ID: 15124543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer.
    Vora SA; Wong WW; Schild SE; Ezzell GA; Halyard MY
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1053-8. PubMed ID: 17398023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using decision analysis to determine the cost-effectiveness of intensity-modulated radiation therapy in the treatment of intermediate risk prostate cancer.
    Konski A; Watkins-Bruner D; Feigenberg S; Hanlon A; Kulkarni S; Beck JR; Horwitz EM; Pollack A
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):408-15. PubMed ID: 16887291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk-adapted androgen deprivation and escalated three-dimensional conformal radiotherapy for prostate cancer: Does radiation dose influence outcome of patients treated with adjuvant androgen deprivation? A GICOR study.
    Zapatero A; Valcárcel F; Calvo FA; Algás R; Béjar A; Maldonado J; Villá S
    J Clin Oncol; 2005 Sep; 23(27):6561-8. PubMed ID: 16170164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of late rectal toxicity from conventional versus three-dimensional conformal radiotherapy for prostate cancer: analysis of clinical and dosimetric factors.
    Lee CM; Lee RJ; Handrahan DL; Sause WT
    Urology; 2005 Jan; 65(1):114-9. PubMed ID: 15667875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of benchmark dose-volume histograms for selection of the optimal technique between three-dimensional conformal radiation therapy and intensity-modulated radiation therapy in prostate cancer.
    Luo C; Yang CC; Narayan S; Stern RL; Perks J; Goldberg Z; Ryu J; Purdy JA; Vijayakumar S
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1253-62. PubMed ID: 17145540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost of radiation therapy.
    Ploquin NP; Dunscombe PB
    Radiother Oncol; 2008 Feb; 86(2):217-23. PubMed ID: 18237802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preliminary results of the assessment of intensity modulated radiotherapy (IMRT) for prostatic and head and neck tumors (STIC 2001)].
    Marchal C; Lapeyre M; Beckendorf V; Aletti P; Haslé E; Dubois JB; Maingon P; Bensadoun RJ; Le Prise E; Lartigau E; Carrie C; Dubray B; Marchesi V; Ailleres N; Naudy S; Marcie S; Manens JP; Mazurier J; Ginestet C; Chauvin F; Pommier P; Gerard JP; Carrere MO
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S121-7. PubMed ID: 15679257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional conformal radiotherapy for hepatocellular carcinoma with inferior vena cava invasion.
    Igaki H; Nakagawa K; Shiraishi K; Shiina S; Kokudo N; Terahara A; Yamashita H; Sasano N; Omata M; Ohtomo K
    Jpn J Clin Oncol; 2008 Jun; 38(6):438-44. PubMed ID: 18495749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy.
    Mock U; Bogner J; Georg D; Auberger T; Pötter R
    Strahlenther Onkol; 2005 Jul; 181(7):448-55. PubMed ID: 15995838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment nomogram predicting ten-year biochemical outcome of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer.
    Zelefsky MJ; Kattan MW; Fearn P; Fearon BL; Stasi JP; Shippy AM; Scardino PT
    Urology; 2007 Aug; 70(2):283-7. PubMed ID: 17826490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma: initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319.
    Vicini F; Winter K; Straube W; Wong J; Pass H; Rabinovitch R; Chafe S; Arthur D; Petersen I; McCormick B
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1531-7. PubMed ID: 16198508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of proton radiation therapy in the treatment of breast cancer.
    Lundkvist J; Ekman M; Ericsson SR; Isacsson U; Jönsson B; Glimelius B
    Radiother Oncol; 2005 May; 75(2):179-85. PubMed ID: 15885828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.